| Market Cap | ₹821Cr |
| ROE | 18.34% |
| P/E Ratio(TTM) | 28.40 |
| EPS(TTM) | 61.21 |
| P/B Ratio | 5.21 |
| Dividend Yield | 0.04% |
| Industry P/E | 39.79 |
| Book Value | 333.71 |
| Debt to Equity | 1.08 |
| Face Value | 10 |
| Parent Organisation | Fredun Pharmaceuticals Ltd |
| Managing Director | Mr. Fredun Medhora |
| Founded | 1987 |
| BSE Symbol | 539730 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.51 | ||
| Ajanta Pharma | NA (0.00%) | 33.61 | ||
| Gland Pharma | NA (0.00%) | 35.69 | ||
| Eris Lifesciences | NA (0.00%) | 51.62 |